SARS-CoV-2 Main Protease Inhibitor High-Throughput Screen

被引:0
|
作者
Delgado, Renee [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA
关键词
Mpro (main protease); high-throughput screening; drug discovery; SARS-CoV-2;
D O I
10.1016/j.jbc.2024.106070
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1217
引用
收藏
页码:S172 / S172
页数:1
相关论文
共 50 条
  • [1] High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors
    Zang, Yi
    Su, Mingbo
    Wang, Qingxing
    Cheng, Xi
    Zhang, Wenru
    Zhao, Yao
    Chen, Tong
    Jiang, Yingyan
    Shen, Qiang
    Du, Juan
    Tan, Qiuxiang
    Wang, Peipei
    Gao, Lixin
    Jin, Zhenming
    Zhang, Mengmeng
    Li, Cong
    Zhu, Ya
    Feng, Bo
    Tang, Bixi
    Xie, Han
    Wang, Ming-Wei
    Zheng, Mingyue
    Pan, Xiaoyan
    Yang, Haitao
    Xu, Yechun
    Wu, Beili
    Zhang, Leike
    Rao, Zihe
    Yang, Xiuna
    Jiang, Hualiang
    Xiao, Gengfu
    Zhao, Qiang
    Li, Jia
    PROTEIN & CELL, 2023, 14 (01) : 17 - 27
  • [2] A cyclic peptide inhibitor of the SARS-CoV-2 main protease
    Kreutzer, Adam G.
    Krumberger, Maj
    Diessner, Elizabeth M.
    Parrocha, Chelsea Marie T.
    Morris, Michael A.
    Guaglianone, Gretchen
    Butts, Carter T.
    Nowick, James S.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 221
  • [3] Protocol for high-throughput screening of SARS-CoV-2 main protease inhibitors using a robust fluorescence polarization assay
    Zhang, Jing
    Yan, Haohao
    Yan, Gangan
    Liu, Xiaoping
    Wang, Yanchang
    Chen, Yunyu
    STAR PROTOCOLS, 2022, 3 (04):
  • [4] A high-throughput response to the SARS-CoV-2 pandemic
    Rasmussen, Lynn
    Sanders, Shalisa
    Sosa, Melinda
    Mckellip, Sara
    Nebane, N. Miranda
    Martinez-Gzegozewska, Yohanka
    Reece, Andrew
    Ruiz, Pedro
    Manuvakhova, Anna
    Zhai, Ling
    Warren, Brooke
    Curry, Aliyah
    Zeng, Qinghua
    Bostwick, J. Robert
    Vinson, Paige N.
    SLAS DISCOVERY, 2024, 29 (05)
  • [5] Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor
    Glaser, Jens
    Sedova, Ada
    Galanie, Stephanie
    Kneller, Daniel W.
    Davidson, Russell B.
    Maradzike, Elvis
    Del Galdo, Sara
    Labbe, Audrey
    Hsu, Darren J.
    Agarwal, Rupesh
    Bykov, Dmytro
    Tharrington, Arnold
    Parks, Jerry M.
    Smith, Dayle M. A.
    Daidone, Isabella
    Coates, Leighton
    Kovalevsky, Andrey
    Smith, Jeremy C.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2022, 5 (04) : 255 - 265
  • [6] A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
    Sievers, Benjamin Louis
    Gelbart, Terri
    Tan, Gene S.
    STAR PROTOCOLS, 2022, 3 (04):
  • [7] Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors
    Breidenbach, Julian
    Lemke, Carina
    Pillaiyar, Thanigaimalai
    Schaekel, Laura
    Al Hamwi, Ghazl
    Diett, Miriam
    Gedschold, Robin
    Geiger, Nina
    Lopez, Vittoria
    Mirza, Salahuddin
    Namasivayam, Vigneshwaran
    Schiedel, Anke C.
    Sylvester, Katharina
    Thimm, Dominik
    Vielmuth, Christin
    Phuong Vu, Lan
    Zyulina, Maria
    Bodem, Jochen
    Guetschow, Michael
    Mueller, Christa E.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2021, 60 (18) : 10423 - 10429
  • [8] Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro)
    Hussin A. Rothan
    Teow Chong Teoh
    Molecular Biotechnology, 2021, 63 : 240 - 248
  • [9] Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro)
    Rothan, Hussin A.
    Teoh, Teow Chong
    MOLECULAR BIOTECHNOLOGY, 2021, 63 (03) : 240 - 248
  • [10] High-throughput screening for a SARS-CoV-2 frameshifting inhibitor using a cell-free protein synthesis system
    Machida, Kodai
    Tanaka, Rin
    Miki, Seraya
    Noseda, Shotaro
    Yuasa-Sunagawa, Mayumi
    Imataka, Hiroaki
    BIOTECHNIQUES, 2024, 76 (04) : 161 - 168